Quotient

JERSEY, Channel Islands, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Dr. Christine Ginocchio as Chief Scientific & Medical Officer (CSMO).

Quotient Limited Announces Appointment of New Chief Scientific & Medical Officer

The stock price of Quotient Limited (NASDAQ: QTNT) increased by over 16% in the previous trading session. This is why it happened.

QTNT Stock Price: Why It Increased Over 16%

The company presented good news regarding a product's potential approval in Europe.

Why Shares of Quotient Limited Soared Friday

JERSEY, Channel Islands, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the launch of the review process of the Expanded Immunohematology (IH) technical file dossier for review by the European notified body. The Company submitted part I of the dossier in September as planned.

Quotient Limited Provides Update on CE Marking Progress of the MosaiQ™ Expanded Immunohematology Microarray

JERSEY, Channel Islands, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today announced that Christian Albrich has been appointed as Chief People Officer of the Company and will begin serving in that role as of today.

Quotient Limited Announces Christian Albrich as Chief People Officer

JERSEY, Channel Islands, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), announced that Jeremy Stackawitz has notified the Company that he is resigning from his position as Chief Commercial Officer.

Quotient Limited Announces Departure of Chief Commercial Officer, Jeremy Stackawitz

Quotient Limited's (QTNT) CEO Manuel O. Mendez on Q1 2022 Results - Earnings Call Transcript

Quotient (QTNT) delivered earnings and revenue surprises of 7.69% and -0.12%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Quotient (QTNT) Reports Q1 Loss, Misses Revenue Estimates

JERSEY, Channel Islands, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today reported its first quarter fiscal 2022 key achievements and summarized recent business developments.

Quotient Limited Provides First Quarter Fiscal 2022 Results and Business Update

Quotient (QTNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Quotient (QTNT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

JERSEY, Channel Islands, July 02, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), announced that Peter Buhler has notified the Company that he is resigning from his position as Chief Financial Officer to take a position with another company.

Quotient Limited Announces Departure of Chief Financial Officer, Peter Buhler

Quotient Technology

Shares pulled back after surging earlier in the year.

Why Quotient Technology Stock Fell 28% in May

Quotient Limited (QTNT) CEO Manuel Mendez on Q4 2021 Results - Earnings Call Transcript

JERSEY, Channel Islands, June 01, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today reported its fourth quarter fiscal 2021 key achievements and summarized recent business developments.

Quotient Limited Provides Fourth Quarter and Full Year Fiscal 2021 Results and provides Business Update

JERSEY, Channel Islands, May 31, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the management team will participate in two upcoming investor conferences.

Quotient Limited to Participate in Upcoming Investor Conferences

JERSEY, Channel Islands, May 24, 2021 (GLOBE NEWSWIRE) -- Quotient Limited ("Quotient") (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that it has agreed to sell $95.0 million aggregate principal amount of its new 4.75% Convertible Senior Notes due 2026 (the "Notes") in a private offering to institutional investors, including funds managed by Highbridge Capital Management, LLC (“Highbridge”). Quotient intends to use the net proceeds from the offering for the continued development of the multimodal, multiplexing MosaiQ platform, to prepare for its commercial launch and for other general corporate purposes. The Convertible Notes contain covenants limiting incurrences of new indebtedness and the granting of liens, subject to exceptions, including exceptions that would allow the company to refinance its existing senior secured notes. Closing of the initial offering is subject to customary closing conditions. Quotient may issue up to an additional $15.0 million aggregate principal amount of the Notes in one or more subsequent offerings.

Quotient Limited Announces New $95 Million Financing Led by Highbridge

JERSEY, Channel Islands, April 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the company has been recognized with a 2021 Red Dot Product Design Award for the full MosaiQ™ by Quotient system.

MosaiQ by Quotient Wins Prestigious Red Dot Design Award

JERSEY, Channel Islands, April 05, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported encouraging result from a study of its MosaiQ Multiplex Molecular Disease Screening (MDS) Microarray, and provided an update regarding progress on the Company's MosaiQ™ Expanded Immunohematology (IH) microarray.

Quotient Limited Reports Further Enhanced Multimodal Capabilities of the MosaiQ Technology

JERSEY, Channel Islands, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that Manuel Mendez has been appointed as Chief Executive Officer of the Company and will begin serving in that role on April 1st, 2021. Franz Walt, who has served as the company's CEO since 2018 is retiring.

Quotient Limited Announces Manuel Mendez as Chief Executive Officer

JERSEY, Channel Islands, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today announced the Company will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Thursday, February 18.

Quotient Limited Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Quotient Limited (QTNT) CEO Franz Walt on Q3 2021 Results - Earnings Call Transcript

Shares of Quotient (NASDAQ:QTNT) moved higher by 1.2% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 21.62% year over year to ($0.29), which were in line with the estimate of ($0.29).

Recap: Quotient Q3 Earnings

JERSEY, Channel Islands, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today reported its third quarter fiscal 2021 results and other notable developments.

Quotient Limited Reports Third Quarter Fiscal 2021 Results and Business Update

On Monday, February 01, Quotient (NASDAQ:QTNT) will release its latest earnings report. Decipher the announcement with Benzinga's help.

News for Quotient Stock (QTNT)